Patents-Review.com
🔗 Permalink
Inventor profile of:

Stephen D. Wolpe

City:

Boyds, Maryland

Country:

United States

Published Applications:

28

Last publication date:

2025-04-10

Top Assignees for applications by Stephen D. Wolpe

The entities that hold a legal rights for patent applications filed by inventor Wolpe Stephen D.:

Recent patent applications by Wolpe Stephen D.

Stephen D. Wolpe from Boyds, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-04-10
US20250115867A1
Chemistry; metallurgy

AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA, 1,3 FUCOSYLTRANSFERASE

 #2 | 2024-08-15
US20240271093A1
Chemistry; metallurgy

AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE

 #3 | 2023-12-28
US20230416681A9
Chemistry; metallurgy

Augmentation of Cell Therapy Efficacy Including Treatment with Alpha 1,3 Fucosyltransferase

 #4 | 2023-06-15
US20230181708A1
Human necessities

IPSC-BASED VACCINE AS A PROPHYLACTIC AND THERAPEUTIC TREATMENT FOR CANCER

 #5 | 2023-01-19
US20230014609A1
Chemistry; metallurgy

MANUFACTURE AND CRYOPRESERVATION OF FUCOSYLATED CELLS FOR THERAPEUTIC USE

 #6 | 2022-12-08
US20220387569A1
Human necessities

INDUCED PLURIPOTENT STEM CELL-BASED CANCER VACCINES

 #7 | 2019-02-28
US20190062694A1
Chemistry; metallurgy

Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use

 #8 | 2019-01-17
US20190017023A1
Chemistry; metallurgy

Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase

 #9 | 2017-05-04
US20170121673A1
Chemistry; metallurgy

Manufacture and Cryopreservation of Fucosylated Cells for Therapeutic Use

 #10 | 2017-03-02
US20170058261A1
Chemistry; metallurgy

Augmentation of Cell Therapy Efficacy Including Treatment With Alpha 1,3 Fucosyltransferase

 #11 | 2014-06-12
US20140161782A1
Chemistry; metallurgy

AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSLYTRANSFERASE

 #12 | 2013-05-30
US20130137629A1
Human necessities

COMBINATION TREATMENT FOR METABOLIC DISORDERS

 #13 | 2010-09-09
US20100227809A1
Human necessities

COMBINATION TREATMENT FOR METABOLIC DISORDERS

 #14 | 2010-02-18
US20100041147A1
Chemistry; metallurgy

HEMOGLOBIN ALPHA CHAIN PEPTIDE FRAGMENTS USEFUL FOR INHIBITING STEM CELL PROLIFERATION

 #15 | 2009-08-13
US20090203793A1
Human necessities

Compounds for the treatment of metabolic disorders

 #16 | 2009-06-18
US20090156681A1
Human necessities

Compounds for the treatment of metabolic disorders

 #17 | 2008-01-17
US20080015209A1
Chemistry; metallurgy

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

 #18 | 2007-11-15
US20070265323A1
Chemistry; metallurgy

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

 #19 | 2007-11-15
US20070265322A1
Chemistry; metallurgy

Method for the treatment of metabolic disorders

 #20 | 2007-10-25
US20070249719A1
Chemistry; metallurgy

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

 #21 | 2007-10-25
US20070249696A1
Chemistry; metallurgy

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

 #22 | 2007-10-18
US20070244172A1
Chemistry; metallurgy

Method for the treatment of metabolic disorders

 #23 | 2007-10-18
US20070244171A1
Chemistry; metallurgy

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

 #24 | 2007-10-18
US20070244141A1
Chemistry; metallurgy

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

 #25 | 2007-05-10
US20070105958A1
Chemistry; metallurgy

Methods for the treatment of metabolic disorders such as diabetes

 #26 | 2006-02-16
US20060035970A1
Human necessities

Treatment of metabolic disorders

 #27 | 2006-01-19
US20060014784A1
Human necessities

Compounds for the treatment of metabolic disorders

 #28 | 2005-02-24
US20050043218A1
Chemistry; metallurgy

Inhibitor of stem cell proliferation and uses thereof
InventorID:

795448 ⎘